Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cardiol Therapeutics's market cap was $87.86M on Nov 11, 2026, against $75.15M a year earlier. Over the last 5 years it ranged from $22.04M to $171.80M, with a median of $75.15M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $87.86M | +28.7% |
| 2025 | Dec 31, 2025 | $68.26M | -17.3% |
| 2024 | Dec 31, 2024 | $82.51M | +56.6% |
| 2023 | Dec 29, 2023 | $52.71M | +139.1% |
| 2022 | Dec 30, 2022 | $22.04M | -60.1% |
| 2021 | Dec 31, 2021 | $55.24M | – |
See a number that looks wrong?